Trans-splicing

Trans-splicing is a special form of RNA processing in eukaryotes where exons from two different primary RNA transcripts are joined end to end and ligated.

Whereas "normal" (cis-)splicing processes a single molecule, trans-splicing generates a single RNA transcript from multiple separate pre-mRNAs. This phenomenon can be exploited for molecular therapy to address mutated gene products.[1]

Trans-splicing can be the mechanism behind certain oncogenic fusion transcripts.[2][3]

Trans-splicing is used by certain microbial organisms, notably protozoa of the Kinetoplastae class to produce variable surface antigens and change from one life stage to another.

References

  1. Iwasaki R, Kiuchi H, Ihara M, Mori T, Kawakami M, Ueda H (Jul 2009). "Trans-splicing as a novel method to rapidly produce antibody fusion proteins". Biochemical and Biophysical Research Communications. 384 (3): 316–21. doi:10.1016/j.bbrc.2009.04.122. PMID 19409879.
  2. Li H, Wang J, Mor G, Sklar J (Sep 2008). "A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells". Science. 321 (5894): 1357–61. doi:10.1126/science.1156725. PMID 18772439.
  3. Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F, Rubin MA (Apr 2009). "SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer". Cancer Research. 69 (7): 2734–8. doi:10.1158/0008-5472.CAN-08-4926. PMID 19293179.

Further reading

  • Dixon RJ, Eperon IC, Samani NJ (Jan 2007). "Complementary intron sequence motifs associated with human exon repetition: a role for intragenic, inter-transcript interactions in gene expression". Bioinformatics. 23 (2): 150–5. doi:10.1093/bioinformatics/btl575. PMID 17105720. 
  • Yang Y, Walsh CE (Dec 2005). "Spliceosome-mediated RNA trans-splicing". Molecular Therapy. 12 (6): 1006–12. doi:10.1016/j.ymthe.2005.09.006. PMID 16226059. 
  • Coady TH, Shababi M, Tullis GE, Lorson CL (Aug 2007). "Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing". Molecular Therapy. 15 (8): 1471–8. doi:10.1038/sj.mt.6300222. PMID 17551501. 
  • Wally V, Murauer EM, Bauer JW (Aug 2012). "Spliceosome-mediated trans-splicing: the therapeutic cut and paste". The Journal of Investigative Dermatology. 132 (8): 1959–66. doi:10.1038/jid.2012.101. PMID 22495179. 


This article is issued from Wikipedia - version of the 8/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.